Physician
Hematology
Dr. Carl G. Kardinal, MD
Carl G. Kardinal practices Hematology. He went to medical school at Washington University School of Medicine in St. Louis. Carl Kardinal is a published doctor and has 80 publications published. The lastest was: 'Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced malignant melanoma.'
Publications
- Altruism-A Coping Mechanism for Patients on Clinical Trials: A Nursing Perspective.
- The changing hope trajectory in patients with advanced-stage Cancer: a nursing perspective.
- Iron Deficiency Anemia Related to Hereditary Hemorrhagic Telangiectasia: Response to Treatment With Bevacizumab.
- Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent met...
- The ochsner Cancer institute clinical trials program.
- Hurricane katrina: the challenge to Cancer clinical research.
- Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastat...
- Randomized phase II study of two irinotecan schedules for patients with metastatic breast Cancer refractory to an anthracycline, a taxane, or both.
- Safety and toxicity analysis of oxaliplatin combined with fluorouracil or as a single agent in patients with previously treated advanced colorectal Cancer.
- Nicotine patch therapy based on smoking rate followed by bupropion for prevention of relapse to smoking.
- Phase II trial of doxorubicin/docetaxel/cyclophosphamide for locally advanced and metastatic breast Cancer: results from NSABP trial BP-58.
- Dronabinol versus megestrol acetate versus combination therapy for Cancer-associated anorexia: a North Central Cancer Treatment Group study.
- A phase II trial of docetaxel and CPT-11 in patients with metastatic adenoCarcinoma of the esophagus, gastroesophageal junction, and gastric cardia.
- Current concepts in breast Cancer. Part II. Pathologic considerations and early diagnosis.
- The breast Cancer prevention trial.
- Recent advances in the management of Cancer of the breast.
- Inflammatory carcinoma of the Breast: therapeutic perspective.
- The psychologic care of the Cancer patient.
- Cancer. A potentially preventable disease.
- Ovarian Cancer: current management.
- Evaluation of a hexamethylmelamine and 5-fluorouracil combination in the treatment of advanced ovarian Carcinoma.
- Second Cancers after prolonged adjuvant thiotepa for operable carcinoma of the breast.
- Current concepts in breast Cancer. Part III. Staging, primary therapy and adjuvant chemotherapy.
- Adriamycin and cis-dichlorodiammineplatinum in nonresectable and metastatic Carcinoma of the lung.
- Cancer of the breast. Endocrine and hormonal therapy.
- Current concepts in breast Cancer management. Part 1. Epidemiologic considerations in breast Cancer in women and men.
- Adriamycin versus adriamycin and bleomycin in advanced epidermoid Carcinoma of the cervix.
- Breast Cancer Prevention Trial update.
- Ethical issues in Cancer clinical trials.
- Evaluation of bleomycin, adriamycin, and vinblastine in combination therapy for advanced testicular Tumors.
- Current concepts in breast Cancer. Part IV. Approach to the patient with advanced disease.
- Cancer of the breast. Chemotherapy.
- Pleural effusion in breast carcinoma: Analysis of 122 cases.
- Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
- Is breast preservation possible in women with large, locally advanced breast Cancers?
- Chemoendocrine therapy vs chemotherapy alone for advanced breast Cancer in postmenopausal women: preliminary report of a randomized study.
- Chemotherapy with cyclophosphamide, adriamycin, and 5-fluorouracil compared to chemotherapy plus hormonal therapy with tamoxifen in the treatment of advanced Breast ca...
- Can breast Cancer be prevented?
- Reactions of patients with advanced Cancer to their diagnosis and treatment.
- Treatment of Acute nonlymphocytic leukemia in the elderly with intermediate high-dose cytosine arabinoside.
- Guest editor.
- Prevention of breast Cancer in high-risk women.
- Treatment of advanced colon Cancer with 5-fluorouracil (NSC19893) versus cyclophosphamide (NSC26271) plus 5-fluorouracil: prognostic aspects of the differential white ...
- Inflammatory breast Cancer: what is the appropriate therapy for patients who have a clinical response to induction chemotherapy?
- The antiemetic efficacy of secobarbital and chlorpromazine compared to metoclopramide, diphenhydramine, and dexamethasone. A randomized trial.
- Phase II trial of edatrexate in small cell lung Cancer.
- Chemohormonal therapy in advanced carcinoma of the breast: Cancer and Leukemia Group B protocol 8081.
- Responses to chemotherapy or chemohormonal therapy in advanced breast Cancer patients treated previously with adjuvant chemotherapy. A subset analysis of CALGB Study 8...
- Hope, consent, and clinical research.
- Phase II trial of recombinant leukocyte A interferon (IFN-alpha 2A) plus 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and the combination cimetidine with BCNU in patien...
- Cancer control research in the North Central Cancer Treatment Group (NCCTG).
- A simple stratification factor prognostic for survival in advanced Cancer: the good/bad/uncertain index.
- Randomized trial of dietician counseling to try to prevent weight gain associated with breast Cancer adjuvant chemotherapy.
- Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.
- Sequencing and schedule effects of cisplatin plus etoposide in small-cell lung Cancer: results of a North Central Cancer Treatment Group randomized clinical trial.
- Biochemical modulation of fluorouracil with leucovorin: confirmatory evidence of improved therapeutic efficacy in advanced colorectal Cancer.
- Phase II study of combined levamisole with recombinant interleukin-2 in patients with advanced Malignant melanoma.
- Investigating four ''myths'' surrounding dysphagia in patients with metastatic esophageal Cancer. A multi-institutional study from the North Central Cancer Treatment G...
- Tamoxifen in treatment of intraductal breast Cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial.
- A phase II study of paclitaxel plus carboplatin as first-line chemotherapy for women with metastatic Breast carcinoma.
- Mitoxantrone dose augmentation utilizing filgrastim support in combination with fixed-dose 5-fluorouracil and leucovorin in women with metastatic breast Cancer.
- Octreotide as first-line treatment for women with metastatic breast Cancer.
- Combined doxorubicin and alpha-interferon therapy of advanced hepatocellular Carcinoma.
- A phase III trial of mitomycin C alone versus mitomycin C, vinblastine, and cisplatin for metastatic squamous cell lung Carcinoma.
- Phase III trial of recombinant interferon gamma in complete responders with small-cell lung Cancer.
- Evaluation of the continuous infusion of etoposide plus cisplatin in metastatic breast Cancer. A collaborative North Central Cancer Treatment Group/Mayo Clinic phase I...
- Tamoxifen and chemotherapy for axillary node-negative, estrogen receptor-negative breast Cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-23.
- Randomized comparison of two schedules of fluorouracil and leucovorin in the treatment of advanced colorectal Cancer.
- Two months of doxorubicin-cyclophosphamide with and without interval reinDuction therapy compared with 6 months of cyclophosphamide, methotrexate, and fluorouracil in ...
- A phase III trial on the therapy of advanced pancreatic Carcinoma. Evaluations of the Mallinson regimen and combined 5-fluorouracil, doxorubicin, and cisplatin.
- A controlled trial of cyproheptadine in Cancer patients with anorexia and/or cachexia.
- A randomized trial of tamoxifen alone or combined with octreotide in the treatment of women with metastatic Breast carcinoma.
- A pilot evaluation of alternating preoperative chemotherapy in the management of patients with locoregionally advanced Breast carcinoma.
- Phase II trial of methotrexate, vinblastine, doxorubicin, and cisplatin in advanced/recurrent Carcinoma of the uterine cervix and vagina.
- Further evaluation of intensified and increased total dose of cyclophosphamide for the treatment of primary breast Cancer: findings from National Surgical Adjuvant Bre...
- Adjuvant therapy with the monoclonal antibody Edrecolomab plus fluorouracil-based therapy does not improve overall survival of patients with stage III colon Cancer.
- Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast Cancer: a phase II trial of the NSABP Foundation Research Group.
- A phase 2 study of gemcitabine and epirubicin for the treatment of pleural mesothelioma: a North Central Cancer Treatment Study, N0021.
- A Phase I/II study of GTI-2040 and capecitabine in patients with renal cell Carcinoma.
Schools
Washington Center School of Medicine
Procedures Preformed
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Pathway X Bronze Direct CACA IN HIX
- Anthem Blue Cross Blue Shield PPO
- Assurant Health
- Blue Card PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Cofinity PPO
- Commercial Insurance Company
- Coventry Health Care
- First Health (Coventry Health Care) PPO
- Group Health Cooperative
- Kaiser Permanente
- Medicaid
- Medicare MCR
- Medico
- Old Surety Life Insurance CompanyMedicare MCR
- United Healthcare
Education
-
Naval Medical Center -
Washington University School of Medicine in St. Louis
Helpful Reviews
Similar Doctors
|
Dr. Umasankar Ramadoss, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael C. Trendle, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Mary S. Muscato, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shadi M. Haddadin, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Pamela J. Honeycutt, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Tamara V. Hopkins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Radwan F. Khozouz, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William P. Patterson, MD |
|
|
Dr. Felipe B. Manalo, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Elangovan Balakrishnan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Carl E. Freter, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Shahid X. Waheed, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael X. Wang, MD |